• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒核心蛋白1区的生物信息学分析:伊朗

Bioinformatics Analysis of Domain 1 of HCV-Core Protein: Iran.

作者信息

Dehghani Behzad, Hashempour Tayebeh, Hasanshahi Zahra, Moayedi Javad

机构信息

Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, 71937 Iran.

出版信息

Int J Pept Res Ther. 2020;26(1):303-320. doi: 10.1007/s10989-019-09838-y. Epub 2019 Apr 20.

DOI:10.1007/s10989-019-09838-y
PMID:32435167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7223762/
Abstract

Hepatitis C virus (HCV) infection is a serious global health problem and a cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Bioinformatics software has been an effective tool to study the HCV genome as well as core domains. Our research was based on employing several bioinformatics software applications to find important mutations in domain 1 of core protein in Iranian HCV infected samples from 2006 to 2017, and an investigation of general properties, B-cell and T-cell epitopes, modification sites, and structure of domain 1. Domain 1 sequences of 188 HCV samples isolated from 2006 to 2017, Iran, were retrieved from NCBI gene bank. Using several tools, all sequences were analyzed for determination of mutations, physicochemical analysis, B-cell epitopes prediction, T-cell and CTL epitopes prediction, post modification, secondary and tertiary structure prediction. Our analysis determined several mutations in some special positions (70, 90, 91, and 110) that are associated with HCC and hepatocarcinogenesis, efficacy of triple therapy and sustained virological response, and interaction between core and CCR6. Several B-cell, T-cell, and CTL epitopes were recognized. Secondary and tertiary structures were mapped fordomain1 and core proteins. Our study, as a first report, offered inclusive data about frequent mutation in HCV-core gene domain 1 in Iranian sequences that can provide helpful analysis on structure and function of domain 1 of the core gene.

摘要

丙型肝炎病毒(HCV)感染是一个严重的全球健康问题,是慢性肝炎、肝硬化和肝细胞癌(HCC)的病因。生物信息学软件一直是研究HCV基因组以及核心结构域的有效工具。我们的研究基于使用多种生物信息学软件应用程序,以在2006年至2017年伊朗HCV感染样本的核心蛋白结构域1中寻找重要突变,并对结构域1的一般特性、B细胞和T细胞表位、修饰位点及结构进行研究。从NCBI基因库中检索了2006年至2017年从伊朗分离的188个HCV样本的结构域1序列。使用多种工具,对所有序列进行分析,以确定突变、理化分析、B细胞表位预测、T细胞和CTL表位预测、翻译后修饰、二级和三级结构预测。我们的分析确定了一些特殊位置(70、90、91和110)的几个突变,这些突变与HCC和肝癌发生、三联疗法的疗效和持续病毒学应答以及核心与CCR6之间的相互作用有关。识别出了几个B细胞、T细胞和CTL表位。绘制了结构域1和核心蛋白的二级和三级结构。作为首份报告,我们的研究提供了有关伊朗序列中HCV核心基因结构域1频繁突变的全面数据,可为核心基因结构域1的结构和功能提供有益分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/60ebccf55c51/10989_2019_9838_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/8b8b1220444a/10989_2019_9838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/6270c5d063a8/10989_2019_9838_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/627d581e15a7/10989_2019_9838_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/303210b44891/10989_2019_9838_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/1258d7a48dcb/10989_2019_9838_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/eb9ef888d4c8/10989_2019_9838_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/d91202b0e969/10989_2019_9838_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/c9a98db96673/10989_2019_9838_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/03f1c0c9fec0/10989_2019_9838_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/60ebccf55c51/10989_2019_9838_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/8b8b1220444a/10989_2019_9838_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/6270c5d063a8/10989_2019_9838_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/627d581e15a7/10989_2019_9838_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/303210b44891/10989_2019_9838_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/1258d7a48dcb/10989_2019_9838_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/eb9ef888d4c8/10989_2019_9838_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/d91202b0e969/10989_2019_9838_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/c9a98db96673/10989_2019_9838_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/03f1c0c9fec0/10989_2019_9838_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/7223762/60ebccf55c51/10989_2019_9838_Fig10_HTML.jpg

相似文献

1
Bioinformatics Analysis of Domain 1 of HCV-Core Protein: Iran.丙型肝炎病毒核心蛋白1区的生物信息学分析:伊朗
Int J Pept Res Ther. 2020;26(1):303-320. doi: 10.1007/s10989-019-09838-y. Epub 2019 Apr 20.
2
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.丙型肝炎病毒(HCV)特异性细胞毒性T淋巴细胞可识别HCV核心蛋白和包膜蛋白中的表位。
J Virol. 1993 Dec;67(12):7522-32. doi: 10.1128/JVI.67.12.7522-7532.1993.
3
Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.巴西肝癌患者与非肝癌患者的乙型肝炎和丙型肝炎病毒的遗传变异性。
J Med Virol. 2014 Feb;86(2):217-23. doi: 10.1002/jmv.23837. Epub 2013 Nov 6.
4
Cytotoxic T lymphocytes and CD4 epitope mutations in the pre-core/core region of hepatitis B virus in chronic hepatitis B carriers in Northeast Iran.伊朗东北部慢性乙肝携带者中细胞毒性T淋巴细胞及乙肝病毒前核心/核心区域的CD4表位突变
Indian J Gastroenterol. 2017 Jul;36(4):253-257. doi: 10.1007/s12664-017-0767-z. Epub 2017 Jul 25.
5
An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.丙型肝炎病毒核心区域中一个可被小鼠和人类细胞毒性T细胞识别的表位。
J Virol. 1994 May;68(5):3334-42. doi: 10.1128/JVI.68.5.3334-3342.1994.
6
Mutations within the HBc gene of the hepatitis B virus: a study on Iranian patients.乙型肝炎病毒核心蛋白(HBc)基因的突变:对伊朗患者的一项研究。
Clin Lab. 2014;60(1):9-21. doi: 10.7754/clin.lab.2013.130206.
7
Reactivity to B cell epitopes within hepatitis C virus core protein and hepatocellular carcinoma.丙型肝炎病毒核心蛋白内B细胞表位的反应性与肝细胞癌
Cancer Res. 1995 Jan 1;55(1):111-4.
8
Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes.肝癌中人类乙型肝炎病毒的核心抗原突变积聚于MHC II类限制性T细胞表位。
Virology. 1995 Sep 10;212(1):151-62. doi: 10.1006/viro.1995.1463.
9
Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.HBV/HCV相关肝细胞癌中HBV前核心/核心基因的病毒学分析、基因型及突变模式
J Viral Hepat. 2006 Sep;13(9):574-81. doi: 10.1111/j.1365-2893.2006.00726.x.
10
Molecular mechanism of hepatocarcinogenesis.肝癌发生的分子机制。
J Gastroenterol Hepatol. 1997 Oct;12(9-10):S309-13. doi: 10.1111/j.1440-1746.1997.tb00514.x.

引用本文的文献

1
First Report of the Immunogenicity of an Inactivated SARS-CoV-2 (COVID-19) Vaccine in Iranian Patients with Autoimmune Diseases.灭活严重急性呼吸综合征冠状病毒2(COVID-19)疫苗在伊朗自身免疫性疾病患者中的免疫原性首次报告。
Eur J Rheumatol. 2025 Jun 5;12(2):1-6. doi: 10.5152/eurjrheum.2025.24057.
2
Prediction of the Co-receptor usage of the main worldwide HIV-1 subtypes, CRF, and CRF35-AD in Iranian patients via the five genotypic tools.通过五种基因分型工具预测伊朗患者中全球主要HIV-1亚型、CRF及CRF35-AD的共受体使用情况。
Biochem Biophys Rep. 2025 Feb 17;41:101939. doi: 10.1016/j.bbrep.2025.101939. eCollection 2025 Mar.
3

本文引用的文献

1
Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus.探索登革热蛋白质组学,设计有效的基于表位的登革热病毒疫苗。
J Biomol Struct Dyn. 2019 Jul;37(10):2546-2563. doi: 10.1080/07391102.2018.1491890. Epub 2018 Nov 17.
2
Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients.IL-28B血清水平及基因变异在慢性丙型肝炎患者干扰素反应性和晚期肝病中的作用
Med Microbiol Immunol. 2017 Apr;206(2):165-174. doi: 10.1007/s00430-017-0497-y. Epub 2017 Feb 18.
3
Insights into the role of HCV Plus-/Minus strand RNA, IFN-γ and IL-29 in relapse outcome in patients infected with HCV.
HCV immunodominant peptide mapping reveals unique HLA-A*02-restricted signatures: insights for CD8 T-cell-based vaccines and immunotherapies.
丙型肝炎病毒免疫显性肽图谱揭示独特的HLA-A*02限制性特征:对基于CD8 T细胞的疫苗和免疫疗法的启示
Immunogenetics. 2025 Jan 31;77(1):13. doi: 10.1007/s00251-025-01370-2.
4
In silico analysis of human herpes virus-8 genome: a comparison of the K1, VR1, and VR2 regions for genotyping and global geographical distribution.人类疱疹病毒8型基因组的计算机分析:K1、VR1和VR2区域用于基因分型及全球地理分布的比较
Sci Rep. 2025 Jan 2;15(1):326. doi: 10.1038/s41598-024-84376-2.
5
Design of multivalent-epitope vaccine models directed toward the world's population against HIV-Gag polyprotein: Reverse vaccinology and immunoinformatics.针对全球人群的 HIV-Gag 多价表位疫苗模型设计:反向疫苗学和免疫信息学。
PLoS One. 2024 Sep 27;19(9):e0306559. doi: 10.1371/journal.pone.0306559. eCollection 2024.
6
Reverse vaccinology approaches to design a potent multiepitope vaccine against the HIV whole genome: immunoinformatic, bioinformatics, and molecular dynamics approaches.反向疫苗学方法设计针对 HIV 全基因组的有效多表位疫苗:免疫信息学、生物信息学和分子动力学方法。
BMC Infect Dis. 2024 Aug 28;24(1):873. doi: 10.1186/s12879-024-09775-2.
7
Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults.一线抗逆转录病毒治疗失败的预测因素:伊朗 HIV 阳性成年人的横断面研究。
BMC Infect Dis. 2024 Mar 28;24(1):358. doi: 10.1186/s12879-024-09251-x.
8
Comparison of the inhibitory and stimulatory effects of Core and NS3 candidate HCV vaccines on the cellular immune response.核心蛋白和NS3候选丙型肝炎病毒疫苗对细胞免疫反应的抑制和刺激作用比较。
Am J Clin Exp Immunol. 2023 Dec 15;12(6):153-163. eCollection 2023.
9
Hepatitis C virus non-structural proteins modulate cellular kinases for increased cytoplasmic abundance of host factor HuR and facilitate viral replication.丙型肝炎病毒非结构蛋白调节细胞激酶以增加宿主因子 HuR 的细胞质丰度,并促进病毒复制。
PLoS Pathog. 2023 Aug 4;19(8):e1011552. doi: 10.1371/journal.ppat.1011552. eCollection 2023 Aug.
10
An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA.与 HCV RNA 相比,丙型肝炎病毒核心抗原中的一个氨基酸取代限制了其作为 HCV 感染可靠指标的用途。
PLoS One. 2023 Jun 29;18(6):e0287694. doi: 10.1371/journal.pone.0287694. eCollection 2023.
丙型肝炎病毒(HCV)正负链RNA、干扰素-γ(IFN-γ)和白细胞介素-29(IL-29)在HCV感染患者复发结局中的作用研究
Asian Pac J Allergy Immunol. 2015 Sep;33(3):173-81. doi: 10.12932/AP0570.33.3.2015.
4
Association between Human Leukocyte Antigen class-I and hepatitis C: the first report in Azeri patients.人类白细胞抗原I类与丙型肝炎之间的关联:阿塞拜疆患者中的首例报告。
Pak J Biol Sci. 2014 Jun;17(6):872-5. doi: 10.3923/pjbs.2014.872.875.
5
Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.伊朗地中海贫血患者中人类白细胞抗原 II 类等位基因与丙型肝炎病毒清除和持续感染的关联。
J Med Virol. 2015 Sep;87(9):1565-72. doi: 10.1002/jmv.24211. Epub 2015 May 12.
6
In Silico Functional and Structural Characterization of H1N1 Influenza A Viruses Hemagglutinin, 2010-2013, Shiraz, Iran.2010 - 2013年伊朗设拉子甲型H1N1流感病毒血凝素的计算机功能与结构表征
Acta Biotheor. 2015 Jun;63(2):183-202. doi: 10.1007/s10441-015-9260-1. Epub 2015 May 12.
7
Detection of Specific Antibodies to HCV-ARF/CORE+1 Protein in Cirrhotic and Non-Cirrhotic Patients with Hepatitis C: A Possible Association with Progressive Fibrosis.丙型肝炎肝硬化和非肝硬化患者中针对HCV-ARF/CORE+1蛋白的特异性抗体检测:与进行性纤维化的可能关联
Arch Iran Med. 2015 May;18(5):304-7.
8
F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C.F蛋白可增加慢性丙型肝炎患者体内CD4+CD25+ T细胞数量。
Pathog Dis. 2015 Jun;73(4). doi: 10.1093/femspd/ftv022. Epub 2015 Apr 9.
9
The relationship between HLA-G and viral loads in non-responder HCV-infected patients after combined therapy with IFN-α2α and ribavirin.在接受α-2α干扰素和利巴韦林联合治疗后无反应的丙型肝炎病毒感染患者中,HLA-G与病毒载量之间的关系。
Hum Immunol. 2015 Mar;76(2-3):181-6. doi: 10.1016/j.humimm.2014.12.012. Epub 2014 Dec 11.
10
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.HCV 的体液免疫反应:理解是疫苗开发的关键。
Front Immunol. 2014 Nov 10;5:550. doi: 10.3389/fimmu.2014.00550. eCollection 2014.